Market cap
$266 Mln
Revenue (TTM)
$48 Mln
P/E Ratio
--
P/B Ratio
1.2
Div. Yield
0 %
Key Ratios and Highlights
| Growth Score (%) | Quarterly | Annual (TTM) | |||
|---|---|---|---|---|---|
| Particulars | QoQ | YoY | 1-Year | 3-Years | 5-Years |
| Revenue | 683.94 | 84.46 | -32.07 | -1.78 | -3.09 |
| EBIT | 89.33 | 94.94 | 71.94 | 21.76 | 11.08 |
| Net Profit | 102.47 | 100.92 | 98.17 | 25.69 | 12.76 |
| EPS | 102.42 | 100.89 | 97.66 | 25.81 | -- |
| Book Value | -- | -- | -18.93 | -35.58 | -- |
| Key Ratios (%) | Average | Annual (TTM) | |||
|---|---|---|---|---|---|
| Particulars | 3-Years | 5-Years | TTM | Dec-24 | Dec-23 |
| EBIT-Margin
| -260.66 | -275.24 | -122.71 | -278.75 | -215.87 |
| Net Margin
| -260.52 | -322.08 | -8.46 | -- | -- |
| Return on equity
| -59.10 | -109.08 | -1.85 | -24.56 | -76.91 |
| Return on Capital
| -31.08 | -47.06 | -- | -11.85 | -39.83 |
| Return on Assets
| -27.48 | -36.20 | -0.75 | -10.96 | -35.61 |
| Debt to Equity (x)
| -- | -- | 0.00 | 1.16 | 1.01 |
Profitability
ROCE
--
--
Earning before interest and taxes / (Average net worth + Average total Debt) * 100
|
Company Name
|
TTM
|
Dec-24
|
Dec-23
|
Dec-22
|
Dec-21
|
|---|---|---|---|---|---|
|
2seventy bio (TSVT)
|
--
|
-11.85
|
-39.83
|
-41.57
|
-69.22
|
|
Peer Median
|
--
|
--
|
--
|
--
|
--
|
ROE
-1.85
Higher than Peers by 38.44
Profit after tax / Average Net worth * 100
|
Company Name
|
TTM
|
Dec-24
|
Dec-23
|
Dec-22
|
Dec-21
|
|---|---|---|---|---|---|
|
2seventy bio (TSVT)
|
-1.85
|
-24.56
|
-76.91
|
-75.83
|
-134.52
|
|
Peer Median
|
-40.29
|
--
|
--
|
--
|
--
|
ROA
-0.75
Higher than Peers by 30.09
Profit after tax / Average Total assets * 100
|
Company Name
|
TTM
|
Dec-24
|
Dec-23
|
Dec-22
|
Dec-21
|
|---|---|---|---|---|---|
|
2seventy bio (TSVT)
|
-0.75
|
-10.96
|
-35.61
|
-35.89
|
-54.50
|
|
Peer Median
|
-30.84
|
--
|
--
|
--
|
--
|
EBIT Margin
-122.71
Lower than Peers by 40.50
Operating profit (EBIT) / Net Sales * 100
|
Company Name
|
TTM
|
Dec-24
|
Dec-23
|
Dec-22
|
Dec-21
|
|---|---|---|---|---|---|
|
2seventy bio (TSVT)
|
-122.71
|
-278.75
|
-215.87
|
-287.34
|
-535.95
|
|
Peer Median
|
-82.21
|
--
|
--
|
--
|
--
|
Net Margin
-8.46
Higher than Peers by 81.42
Net profit / Total Income (Net sales plus other income) * 100
|
Company Name
|
TTM
|
Dec-24
|
Dec-23
|
Dec-22
|
Dec-21
|
|---|---|---|---|---|---|
|
2seventy bio (TSVT)
|
-8.46
|
-151.20
|
-216.73
|
-260.52
|
-383.64
|
|
Peer Median
|
-89.88
|
--
|
--
|
--
|
--
|
Cash Profit Margin
0.00
Higher than Peers by 0.00
(Net profit + Depreciation) / Gross Sales * 100
|
Company Name
|
TTM
|
Dec-24
|
Dec-23
|
Dec-22
|
Dec-21
|
|---|---|---|---|---|---|
|
2seventy bio (TSVT)
|
0.00
|
--
|
--
|
--
|
--
|
|
Peer Median
|
0.00
|
--
|
--
|
--
|
--
|
Revenue Growth
-32.07
Lower than Peers by 86.11
Year on year growth in net sales
|
Company Name
|
TTM
|
Dec-24
|
Dec-23
|
Dec-22
|
Dec-21
|
|---|---|---|---|---|---|
|
2seventy bio (TSVT)
|
-32.07
|
-0.62
|
0.10
|
0.68
|
-0.78
|
|
Peer Median
|
54.03
|
--
|
--
|
--
|
--
|
EBIT Growth
71.94
Higher than Peers by 72.90
Year on year growth in operating profit (EBIT)
|
Company Name
|
TTM
|
Dec-24
|
Dec-23
|
Dec-22
|
Dec-21
|
|---|---|---|---|---|---|
|
2seventy bio (TSVT)
|
71.94
|
51.30
|
17.57
|
10.03
|
-102.03
|
|
Peer Median
|
-0.95
|
--
|
--
|
--
|
--
|
Net Profit Growth
98.17
Higher than Peers by 105.35
Year on year growth in profit after tax
|
Company Name
|
TTM
|
Dec-24
|
Dec-23
|
Dec-22
|
Dec-21
|
|---|---|---|---|---|---|
|
2seventy bio (TSVT)
|
98.17
|
73.69
|
14.39
|
13.03
|
-111.49
|
|
Peer Median
|
-7.19
|
--
|
--
|
--
|
--
|
EPS Growth
97.66
Higher than Peers by 83.23
Year on year growth in earnings per share
|
Company Name
|
TTM
|
Dec-24
|
Dec-23
|
Dec-22
|
Dec-21
|
|---|---|---|---|---|---|
|
2seventy bio (TSVT)
|
97.66
|
0.74
|
0.36
|
0.46
|
-1.06
|
|
Peer Median
|
14.43
|
--
|
--
|
--
|
--
|
Book Value Growth
0.51
Higher than Peers by 10.98
Year on year growth in book value per share
|
Company Name
|
TTM
|
Dec-24
|
Dec-23
|
Dec-22
|
Dec-21
|
|---|---|---|---|---|---|
|
2seventy bio (TSVT)
|
0.51
|
--
|
--
|
--
|
--
|
|
Peer Median
|
-10.46
|
--
|
--
|
--
|
--
|
Solvency
Debt to Equity
--
--
Total debt / Net worth
|
Company Name
|
TTM
|
Dec-24
|
Dec-23
|
Dec-22
|
Dec-21
|
|---|---|---|---|---|---|
|
2seventy bio (TSVT)
|
--
|
1.16
|
1.01
|
0.87
|
0.78
|
|
Peer Median
|
--
|
--
|
--
|
--
|
--
|
Short term debt to equity ratio
0.08
--
(Short term borrowings / Net worth)
|
Company Name
|
TTM
|
Dec-24
|
Dec-23
|
Dec-22
|
Dec-21
|
|---|---|---|---|---|---|
|
2seventy bio (TSVT)
|
0.08
|
0.08
|
0.05
|
0.04
|
0.05
|
|
Peer Median
|
--
|
--
|
--
|
--
|
--
|
Current Ratio
4.80
Lower than Peers by 1.01
Current Assets / Current Liabilities and Provisions
|
Company Name
|
TTM
|
Dec-24
|
Dec-23
|
Dec-22
|
Dec-21
|
|---|---|---|---|---|---|
|
2seventy bio (TSVT)
|
4.80
|
4.67
|
3.98
|
3.77
|
2.96
|
|
Peer Median
|
5.80
|
--
|
--
|
--
|
--
|
Quick Ratio
4.80
Lower than Peers by 0.90
(Current Assets - Inventory) / Current Liabilities and Provisions
|
Company Name
|
TTM
|
Dec-24
|
Dec-23
|
Dec-22
|
Dec-21
|
|---|---|---|---|---|---|
|
2seventy bio (TSVT)
|
4.80
|
--
|
3.75
|
3.60
|
4.12
|
|
Peer Median
|
5.69
|
--
|
--
|
--
|
--
|
Interest Coverage
--
--
Earning before interest and taxes (EBIT) / Interest Expenses
|
Company Name
|
TTM
|
Dec-24
|
Dec-23
|
Dec-22
|
Dec-21
|
|---|---|---|---|---|---|
|
2seventy bio (TSVT)
|
--
|
--
|
-25.45
|
-30.88
|
-1.06
|
|
Peer Median
|
-2.09
|
--
|
--
|
--
|
--
|
Operating Efficiency
Debtors to sales
49.47
Higher than Peers by 30.50
Debtors outstanding / Net Sales * 100
|
Company Name
|
TTM
|
Dec-24
|
Dec-23
|
Dec-22
|
Dec-21
|
|---|---|---|---|---|---|
|
2seventy bio (TSVT)
|
49.47
|
20.55
|
13.36
|
22.91
|
31.17
|
|
Peer Median
|
18.97
|
--
|
--
|
--
|
--
|
Asset Turnover
0.09
Higher than Peers by 0.02
Sales / Average Total Assets
|
Company Name
|
TTM
|
Dec-24
|
Dec-23
|
Dec-22
|
Dec-21
|
|---|---|---|---|---|---|
|
2seventy bio (TSVT)
|
0.09
|
0.07
|
0.16
|
0.13
|
0.10
|
|
Peer Median
|
0.07
|
--
|
--
|
--
|
--
|
Receivable days
--
--
Average Debtors / Sales * 365
|
Company Name
|
TTM
|
Dec-24
|
Dec-23
|
Dec-22
|
Dec-21
|
|---|---|---|---|---|---|
|
2seventy bio (TSVT)
|
--
|
102.22
|
62.53
|
75.76
|
92.74
|
|
Peer Median
|
--
|
--
|
--
|
--
|
--
|
Inventory Days
--
--
Average Inventory / Sales * 365
|
Company Name
|
TTM
|
Dec-24
|
Dec-23
|
Dec-22
|
Dec-21
|
|---|---|---|---|---|---|
|
2seventy bio (TSVT)
|
--
|
220.78
|
294.44
|
-699.88
|
978.35
|
|
Peer Median
|
--
|
--
|
--
|
--
|
--
|
Payable days
--
--
Average Creditors / Cost of goods sold * 365
|
Company Name
|
TTM
|
Dec-24
|
Dec-23
|
Dec-22
|
Dec-21
|
|---|---|---|---|---|---|
|
2seventy bio (TSVT)
|
--
|
57.33
|
142.88
|
92.17
|
956.01
|
|
Peer Median
|
--
|
--
|
--
|
--
|
--
|
Cash Conversion Cycle
--
--
Receivable Days + Inventory Days - Payable Days
|
Company Name
|
TTM
|
Dec-24
|
Dec-23
|
Dec-22
|
Dec-21
|
|---|---|---|---|---|---|
|
2seventy bio (TSVT)
|
--
|
265.67
|
214.09
|
-716.29
|
115.08
|
|
Peer Median
|
--
|
--
|
--
|
--
|
--
|
Valuation
Price / Earnings
--
--
Current share price divided by earning per share in the last twelve months
|
Company Name
|
TTM
|
Dec-24
|
Dec-23
|
Dec-22
|
Dec-21
|
|---|---|---|---|---|---|
|
2seventy bio (TSVT)
|
--
|
-2.69
|
-1.01
|
-1.41
|
-2.09
|
|
Peer Median
|
--
|
--
|
--
|
--
|
--
|
Price / Book Value
1.24
Lower than Peers by 4.11
Current share price divided by book value per share in the latest financial year
|
Company Name
|
TTM
|
Dec-24
|
Dec-23
|
Dec-22
|
Dec-21
|
|---|---|---|---|---|---|
|
2seventy bio (TSVT)
|
1.24
|
0.73
|
0.86
|
1.16
|
1.70
|
|
Peer Median
|
5.35
|
--
|
--
|
--
|
--
|
Dividend Yield
--
--
Dividend per share in the past twelve months divided by current share price
|
Company Name
|
TTM
|
Dec-24
|
Dec-23
|
Dec-22
|
Dec-21
|
|---|---|---|---|---|---|
|
2seventy bio (TSVT)
|
--
|
--
|
--
|
--
|
--
|
|
Peer Median
|
--
|
--
|
--
|
--
|
--
|
EV/EBITDA
-1.29
--
Enterprise Value (Current Market Capitalisation + Total Debt - Cash & Equivalents) / Earnings before interest, taxes, depreciation and taxes (EBITDA)
|
Company Name
|
TTM
|
Dec-24
|
Dec-23
|
Dec-22
|
Dec-21
|
|---|---|---|---|---|---|
|
2seventy bio (TSVT)
|
-1.29
|
-2.26
|
-1.26
|
-1.45
|
39.19
|
|
Peer Median
|
--
|
--
|
--
|
--
|
--
|
Market Cap
266
Higher than Peers by 119
Current Share price multiplied by latest total number of shares outstanding
|
Company Name
|
TTM
|
Dec-24
|
Dec-23
|
Dec-22
|
Dec-21
|
|---|---|---|---|---|---|
|
2seventy bio (TSVT)
|
266
|
--
|
--
|
--
|
--
|
|
Peer Median
|
147
|
--
|
--
|
--
|
--
|